TGFB1 and cancer: It has been shown that inhibition of the TGF-β pathway attenuates the epithelial-mesenchymal transition (EMT) and fibrosis in cancer (Shinto et al., 2010[30]; Tsukada et al., 2013[35]; Shinbo et al., 2015[29]).